Skip to Main Content

WASHINGTON — As the world grapples with a monkeypox outbreak, the Biden administration has been quick to highlight the vaccines and other therapies the United States has in its national stockpile. It’s been far less open about exactly how many of those medicines it has.

Right now, the country hasn’t seen many actual cases of monkeypox — only 40 confirmed cases as of Wednesday. But as global concern grows, officials are walking a tightrope, attempting to assuage public concerns while being cautious on both negotiations about sharing medicines abroad and what they say are national security issues.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment